The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1374
Prothrombin Complex Concentrates to Reverse Warfarin-Related Bleeding
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Warfarin-related bleeding, especially intracranial hemorrhage, can be catastrophic. Several products are available to reverse warfarin’s anticoagulant effect.1

VITAMIN K — The vitamin K-dependent coagulation factors are II, VII, IX and X. Administration of vitamin K can take more than 24 hours to fully restore these factors. In patients with serious or life-threatening warfarin-related bleeding, vitamin K is usually given IV in a dose of 10 mg over about 30 minutes (to reduce the risk of anaphylaxis), and fresh-frozen plasma, recombinant factor VIIa or prothrombin complex concentrate (PCC) may be given in addition.2

FRESH-FROZEN PLASMA — The plasma product most likely to be available in emergency departments to rapidly replace vitamin K-dependent clotting factors is fresh-frozen plasma (FFP). When the speed of replacement ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Prothrombin Complex Concentrates to Reverse Warfarin-Related Bleeding
Article code: 1374c
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian